What are the views of three key stakeholder groups on extending the breast screening interval for low-risk women? A secondary qualitative analysis
Name:
36305519.pdf
Size:
321.0Kb
Format:
PDF
Description:
Identified with Open Access button
Affiliation
School of Health Sciences, Manchester Centre of Health Psychology, Division of Psychology and Mental Health, University of Manchester, Manchester, UKIssue Date
2022
Metadata
Show full item recordAbstract
Introduction: There is increasing interest in risk-stratified breast screening, whereby the prevention and early detection offers vary by a woman's estimated risk of breast cancer. To date, more focus has been directed towards high-risk screening pathways rather than considering women at lower risk, who may be eligible for extended screening intervals. This secondary data analysis aimed to compare the views of three key stakeholder groups on how extending screening intervals for low-risk women should be implemented and communicated as part of a national breast screening programme. Methods: Secondary data analysis of three qualitative studies exploring the views of distinct stakeholder groups was conducted. Interviews took place with 23 low-risk women (identified from the BC-Predict study) and 17 national screening figures, who were involved in policy-making and implementation. In addition, three focus groups and two interviews were conducted with 26 healthcare professionals. A multiperspective thematic analysis was conducted to identify similarities and differences between stakeholders. Findings: Three themes were produced: Questionable assumptions about negative consequences, highlighting how other stakeholders lack trust in how women are likely to understand extended screening intervals; Preserving the integrity of the programme, centring on decision-making and maintaining a positive reputation of breast screening and Negotiating a communication pathway highlighting communication expectations and public campaign importance. Conclusions: A risk-stratified screening programme should consider how best to engage women assessed as having a low risk of breast cancer to ensure mutual trust, balance the practicality of change whilst ensuring acceptability, and carefully develop multilevel inclusive communication strategies.Citation
Taylor G, McWilliams L, Woof VG, Evans DG, French DP. What are the views of three key stakeholder groups on extending the breast screening interval for low-risk women? A secondary qualitative analysis. Health expectations : an international journal of public participation in health care and health policy. 2022 Oct 28. PubMed PMID: 36305519. Epub 2022/10/29. eng.Journal
Health ExpectationsDOI
10.1111/hex.13637PubMed ID
36305519Additional Links
https://dx.doi.org/10.1111/hex.13637Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1111/hex.13637
Scopus Count
Collections
Related articles
- Healthcare professionals' views following implementation of risk stratification into a national breast cancer screening programme.
- Authors: Hawkins R, McWilliams L, Ulph F, Evans DG, French DP
- Issue date: 2022 Oct 12
- Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?
- Authors: McWilliams L, Woof VG, Donnelly LS, Howell A, Evans DG, French DP
- Issue date: 2021 May 29
- Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening.
- Authors: Woof VG, McWilliams L, Donnelly LS, Howell A, Evans DG, Maxwell AJ, French DP
- Issue date: 2021 Jan-Dec
- Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders' views on a low-risk breast screening pathway.
- Authors: McWilliams L, Woof VG, Donnelly LS, Howell A, Evans DG, French DP
- Issue date: 2020 Jul 22
- A stakeholder analysis to prepare for real-world evaluation of integrating artificial intelligent algorithms into breast screening (PREP-AIR study): a qualitative study using the WHO guide.
- Authors: Newlands R, Bruhn H, Díaz MR, Lip G, Anderson LA, Ramsay C
- Issue date: 2024 May 2